Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride safely lowers DHT levels without affecting hormone levels, helping with conditions like enlarged prostate, acne, and hair loss.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Hormonal birth control can cause skin issues, but low-dose options and those with antiandrogens may reduce these effects.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Finasteride and dutasteride might lower melanoma risk.

DHT, not testosterone, mainly affects hair growth and related conditions.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

Eating a balanced diet with vitamins, micronutrients, and antioxidants is important for hair health and can help with hair loss.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss in women may have causes other than hormones.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.